The pharmaceutical industry in Bangladesh has grown at 15% annually since being introduced in the 1980s. It is dominated by a few large players that control over half the market, including Beximco and Square, which hold 8.5% and 10.4% respectively. Barriers to entry for new companies are high due to capital requirements, established brands, and economies of scale of existing competitors. The industry has potential for growth but starting a new pharmaceutical business in Bangladesh poses high risks.